News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for March 2018 Shelley Wood April 02, 2018
News Conference News ACC 2018 High CRP Linked to Bigger Absolute Drops in CV Events for Patients Taking Evolocumab Michael O'Riordan March 20, 2018
News Conference News ACC 2018 ACC 2018: More PCSK9 Outcomes, Antiplatelet Insights, and LifeVest Data at Last Shelley Wood March 05, 2018
News Features How Low Can You Go? Concerns Over Aggressive LDL Lowering Eased as PCSK9 Evidence Mounts Michael O'Riordan May 23, 2017
News Conference News ACC 2017 FOURIER: Evolocumab Reduces Risk of CVD Events by 15% Compared With Placebo Michael O'Riordan March 17, 2017
News Daily News Major CVD Outcomes Trial Testing PCSK9 Inhibitor Evolocumab Meets Primary Endpoint Michael O'Riordan February 03, 2017
News Features Year in Review: Physicians Pick the Biggest News of 2016, in Interventional Cardiology and Beyond Shelley Wood December 30, 2016
News Daily News Prior Atherosclerosis Ups the Risk of Dying After Acute MI Michael O'Riordan December 09, 2016
News Daily News Los Antecedentes de Aterosclerosis Aumentan el Riesgo de Morir Post-IAM Michael O'Riordan December 09, 2016
News Industry News Regeneron and Sanofi Announce 18,000-Patient ODYSSEY OUTCOMES Trial of Praluent® Injection Fully Enrolled November 23, 2015
News Industry News A Competitive Analysis of the Global Acute Coronary Syndrome (ACS) Therapeutics Market May 28, 2015